Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.432NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.388NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.112NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.274NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.515NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.370NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.118NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.137NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.632NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.108NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.332NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CU.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.161NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.411NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.217NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.527NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.500NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.147NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.487NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.68NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.121NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AS.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.115NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.127.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.88NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.423NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.550NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.261NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used